BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28005460)

  • 1. The role of alternative splicing in cancer.
    Singh B; Eyras E
    Transcription; 2017 Mar; 8(2):91-98. PubMed ID: 28005460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
    Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
    Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing-factor alterations in cancers.
    Anczuków O; Krainer AR
    RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance.
    Wojtuszkiewicz A; Assaraf YG; Maas MJ; Kaspers GJ; Jansen G; Cloos J
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):673-89. PubMed ID: 25495223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connecting the dots: chromatin and alternative splicing in EMT.
    Warns JA; Davie JR; Dhasarathy A
    Biochem Cell Biol; 2016 Feb; 94(1):12-25. PubMed ID: 26291837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment.
    Lin JC
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JUM is a computational method for comprehensive annotation-free analysis of alternative pre-mRNA splicing patterns.
    Wang Q; Rio DC
    Proc Natl Acad Sci U S A; 2018 Aug; 115(35):E8181-E8190. PubMed ID: 30104386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T; Shkreta L; Chabot B
    Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targeting of splicing in cancer.
    Lee SC; Abdel-Wahab O
    Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional coupling of transcription and splicing.
    Montes M; Becerra S; Sánchez-Álvarez M; Suñé C
    Gene; 2012 Jun; 501(2):104-17. PubMed ID: 22537677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling of RNA Polymerase II Transcription Elongation with Pre-mRNA Splicing.
    Saldi T; Cortazar MA; Sheridan RM; Bentley DL
    J Mol Biol; 2016 Jun; 428(12):2623-2635. PubMed ID: 27107644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks.
    Sebestyén E; Singh B; Miñana B; Pagès A; Mateo F; Pujana MA; Valcárcel J; Eyras E
    Genome Res; 2016 Jun; 26(6):732-44. PubMed ID: 27197215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers.
    Sahin I; George A; Seyhan AA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing and cancer: a systematic review.
    Zhang Y; Qian J; Gu C; Yang Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):78. PubMed ID: 33623018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription and splicing: A two-way street.
    Tellier M; Maudlin I; Murphy S
    Wiley Interdiscip Rev RNA; 2020 Sep; 11(5):e1593. PubMed ID: 32128990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of pre-messenger RNA splicing in stress responses: sending alternative messages and silent messengers.
    Dutertre M; Sanchez G; Barbier J; Corcos L; Auboeuf D
    RNA Biol; 2011; 8(5):740-7. PubMed ID: 21712650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disturbances of alternative splicing in cancer].
    Wiszomirska H; Piekiełko-Witkowska A; Nauman A
    Postepy Biochem; 2011; 57(3):257-65. PubMed ID: 22235651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression.
    Romano E; Pradervand S; Paillusson A; Weber J; Harshman K; Muehlethaler K; Speiser D; Peters S; Rimoldi D; Michielin O
    Clin Cancer Res; 2013 Oct; 19(20):5749-57. PubMed ID: 23948972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A saga of cancer epigenetics: linking epigenetics to alternative splicing.
    Narayanan SP; Singh S; Shukla S
    Biochem J; 2017 Mar; 474(6):885-896. PubMed ID: 28270561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA Splicing and Cancer.
    Wang E; Aifantis I
    Trends Cancer; 2020 Aug; 6(8):631-644. PubMed ID: 32434734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.